Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Divi'S Laboratories Limited, is a listed public company incorporated on 12 October, 1990. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 60.00 cr and the total paid-up capital is INR 53.00 cr.
Divi'S Laboratories Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 39.44% over the previous year. At the same time, it's book networth has increased by 8.67%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 454.5 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 60.5 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Nimmagadda Venkata Ramana | 00005031 | 30 years |
Managing Director | Murali Krishna Prasad Divi
Shareholder
|
00005040 | 34 years |
CEO | Satchandra Kiran Divi
Shareholder
|
00006503 | 23 years |
Kmp | Satchandra Kiran Divi | <HIDDEN> | 5 years |
CFO | Kishore Babu Lingamneni
Shareholder
|
<HIDDEN> | 10 years |
Director | Rajendra Kumar Premchand | 00895990 | 0 years |
Whole-time Director | Nilima Prasad Divi
Shareholder
|
06388001 | 7 years |
Director | Rameshbabu Venkata Nimmagadda | 07854042 | 7 years |
Director | Ganapaty Seru | 07872766 | 7 years |
Director | Sunaina Singh | 08397250 | 6 years |
Director | Veerayya Chowdary Kosaraju | 08485334 | 5 years |
Director | Devendra Rao Sureddy | 10481393 | 1 years |
CS | Satish Choudhury Meka | <HIDDEN> | 5 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
DIVI'S BIOTECH PRIVATE LIMITED |
Active
|
50.0 L | 3 | Telangana |
DIVI'S PROPERTIES PRIVATE LIMITED |
Active
|
1.0 L | 3 | Telangana |
DIVI'S RESORTS AND AGRO FARMS PRIVATE LIMITED |
Active
|
1.0 L | 3 | Telangana |
AVANT GARDE VENTURES LLP |
Active
|
1.0 Cr | 2 | Telangana |
ADONIS CAPITAL INDIA PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | Telangana |
SAATHI HEALTHCARE PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
RKSN E-COMMERCE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
DAKSHAT HEALTHCARE TECHNOLOGIES PRIVATE LIMITED |
Active
|
5.0 L | 1 | Telangana |
RVM HEALTHCARE PRIVATE LIMITED |
Active
|
2.0 L | 1 | Telangana |
BRS MEDICAL ASSOCIATION |
Active
|
10.0 L | 1 | Telangana |
ANANT RAJ LIMITED |
Active
|
68.4 Cr | 1 | Haryana |
GENOME FOUNDATION |
Active
|
81.5 L | 1 | Telangana |
GMR VARALAKSHMI FOUNDATION |
Active
|
0.0 | 1 | Andhra Pradesh |
EUGIA PHARMA SPECIALITIES LIMITED |
Active
|
621.0 Cr | 1 | Telangana |
MY HOME INDUSTRIES PRIVATE LIMITED |
Active
|
51.0 Cr | 1 | Telangana |
CCL PRODUCTS (INDIA) LIMITED |
Active
|
26.7 Cr | 1 | Andhra Pradesh |
NUZIVEEDU SEEDS LIMITED |
Active
|
86.3 Cr | 1 | Telangana |
RELIANCE INDUSTRIES LIMITED |
Active
|
6,766.2 Cr | 1 | Maharashtra |
TATA MOTORS LIMITED |
Active
|
736.2 Cr | 1 | Maharashtra |
RELIANCE JIO INFOCOMM LIMITED |
Active
|
45,000.0 Cr | 1 | Gujarat |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Divis Laboratories (USA) Inc | United States | - | - |
Divi's Laboratories Europe AG | Switzerland | - | - |
The incorporation date of DIVI'S LABORATORIES LIMITED is 12 October, 1990
The authorized share capital of DIVI'S LABORATORIES LIMITED is INR ₹ 60.0 Cr.
The paid-up capital of DIVI'S LABORATORIES LIMITED is INR ₹ 53.0 Cr.
The registered address of DIVI'S LABORATORIES LIMITED is 1-72/23(P)/DIVIS/303, Divi Towers Cyber Hills, Gachibowli Hyderabad Hyderabad Telangana - 500032
The CIN number of DIVI'S LABORATORIES LIMITED is L24110TG1990PLC011854.